Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in Sweden

Background: Randomised controlled trials have demonstrated prolonged survival with new upfront treatments in addition to standard androgen deprivation therapy (ADT) in men with de novo metastatic castration-sensitive prostate cancer. We describe patient characteristics, time trends and regional d...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Rolf Gedeborg, Fredrik Sandin, Camilla Thellenberg-Karlsson, Johan Styrke, Ingela Franck Lissbrant, Hans Garmo, Pär Stattin
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Medical journals sweden AB 2023-11-01
Цуврал:	Scandinavian Journal of Urology
Нөхцлүүд:	prostate cancer castration sensitive prostate cancer abiraterone enzalutamide apalutamide docetaxel
Онлайн хандалт:	https://medicaljournalssweden.se/SJU/article/view/9572
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!